全文获取类型
收费全文 | 1488篇 |
免费 | 42篇 |
国内免费 | 19篇 |
专业分类
儿科学 | 10篇 |
妇产科学 | 3篇 |
基础医学 | 32篇 |
临床医学 | 219篇 |
内科学 | 432篇 |
皮肤病学 | 1篇 |
神经病学 | 240篇 |
特种医学 | 151篇 |
外科学 | 87篇 |
综合类 | 237篇 |
预防医学 | 24篇 |
眼科学 | 1篇 |
药学 | 94篇 |
中国医学 | 16篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 17篇 |
2022年 | 32篇 |
2021年 | 51篇 |
2020年 | 52篇 |
2019年 | 50篇 |
2018年 | 63篇 |
2017年 | 41篇 |
2016年 | 30篇 |
2015年 | 59篇 |
2014年 | 126篇 |
2013年 | 96篇 |
2012年 | 67篇 |
2011年 | 74篇 |
2010年 | 72篇 |
2009年 | 74篇 |
2008年 | 78篇 |
2007年 | 91篇 |
2006年 | 80篇 |
2005年 | 49篇 |
2004年 | 45篇 |
2003年 | 29篇 |
2002年 | 37篇 |
2001年 | 32篇 |
2000年 | 39篇 |
1999年 | 28篇 |
1998年 | 25篇 |
1997年 | 30篇 |
1996年 | 22篇 |
1995年 | 8篇 |
1994年 | 14篇 |
1993年 | 7篇 |
1992年 | 9篇 |
1991年 | 1篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有1549条查询结果,搜索用时 31 毫秒
91.
Temporary Vena Cava Filters and Ultrahigh Streptokinase Thrombolysis Therapy: A Clinical Study 总被引:3,自引:0,他引:3
Lorch H Zwaan M Siemens HJ Wagner T Kagel C Weiss HD 《Cardiovascular and interventional radiology》2000,23(4):273-278
Purpose: To assess the efficacy of temporary vena cava filters in patients undergoing ultrahigh-dose streptokinase thrombolysis for
iliocaval thrombosis and to determine therapy success and filter and therapy complications.
Methods: Forty-five patients were studied regarding extension and characteristics of thrombosis, duration, success, and complications
of thrombolysis therapy, filter type, access route, pulmonary embolisms, and filter complications.
Results: Complete recanalization was achieved in 57% of cases. Filters were inserted predominantly via a transbrachial route. One
fatal pulmonary embolism (2%) occurred 1 day after starting thrombolysis. No other pulmonary embolism was noted. Other complications
were induced by thrombolysis alone (n = 12), thrombolysis and filter (n = 9), and filter alone (n = 11).
Conclusion: Fatal pulmonary embolisms as a complication of ultrahigh-dose treatment of pelvic or caval thrombosis can not safely be prevented
by the temporary vena cava filters currently available. Filter design needs to be improved. 相似文献
92.
目的 探讨经皮冠状动脉介入治疗(PCI)联合尿激酶静脉溶栓(即优化介入治疗)与直接经皮冠状动脉介入术治疗急性心肌梗死(AMI)合并2型糖尿病(DM)的有效性和安全性。方法 78例发病时间≤12h的首次AMI患者随机分为溶栓治疗+PCI组(45例)和直接PCI组(33例),对2组患者介入治疗前梗死相关血管(IRA)通畅率、介入治疗成功率、出血并发症发生率、住院期间急性心脏缺血事件发生率及出院前左心室功能(LVEF)进行比较。结果 冠状动脉介入治疗前溶栓治疗+PCI组IRA通畅率(53.3%)显著高于直接PCI组(24.3%)(P〈0.05),前者介入治疗成功率98.0%;2组开通率分别为91.1%和87.9%;住院期间2组均无严重出血及急性心脏缺血事件发生;出院前经超声心动图测得LVEF在溶栓治疗+PCI组为64.8%,明显高于直接PCI组57.5%(P〈0.05)。结论 静脉溶栓治疗联合PCI治疗AMI合并2型DM早期再通率高。更有利于保护左室功能,不增加出血并发症。 相似文献
93.
目的 探讨急性心肌梗死溶栓治疗成功是否与QTd、QTcd有关。方法 回顾性测量84例急性心肌梗死患者溶栓治疗后QTd、QTcd的变化,分析比较溶栓成功组与失败组QTd、QTcd值。结果 溶栓成功组与失败组及治疗前相比,QTd、QTcd有显著缩小p〈0.01;而失败组溶栓治疗后QTd、QTcd明显延长p〈0.01。结论 QTd可做为评估急性心肌梗死溶栓成功与否的指标之一。 相似文献
94.
大剂量尿激酶冲击溶栓治疗视网膜中央动脉阻塞 总被引:2,自引:0,他引:2
目的 评价大剂量尿激酶冲击溶栓治疗视网膜中央动脉阻塞的疗效及安全性。方法 对19例病人在发病6h内经静脉给予溶于100ml 5%~10%葡萄糖液的150万U尿激酶进行溶栓治疗。2h后进行眼底荧光造影,观察溶栓及视力恢复情况。结果 19例中,10例视力恢复至0,5以上,4例0.2~0.5,3例0.05~0.1,2例病人治疗前无光感,治疗后无改善、经荧光造影证实10例血管完全再通,再通率52.6%,无严重并发症,结论 大剂量尿激酶冲击溶栓治疗视网膜中央动脉阻塞完全有效,其治疗效果大大好于传统治疗方法。 相似文献
95.
局部动脉溶栓与中医药联合治疗急性颈内动脉系统脑梗死18例临床研究 总被引:1,自引:0,他引:1
目的:评价局部动脉溶栓与中医药联合治疗急性颈内动脉系统脑梗死的短期效果。方法:回顾性分析18例急性颈内动脉系统脑梗死接受局部动脉溶栓与中医药联合治疗病例的临床资料。结果:治疗效果好的患者有14例(78%),总的血管再通率为83%,出血率为16%,死亡率为11%,致残率为11%。结论:局部动脉溶栓与中医药联合治疗治疗急性颈内动脉系统脑梗死是一种有效方法,但安全性和远期疗效还有待于进一步研究和观察。 相似文献
96.
Lupattelli T Basile A Iozzelli A Quarenghi M Nano G Casana R Malacrida G 《Emergency radiology》2005,11(3):164-166
A 18-year-old man presented at our clinic with pain in the right flank following a motorbike accident. The diagnosis of renal artery dissection followed by thrombosis was made by computed tomography and confirmed by angiography. Successful revascularization was performed by means of repeated transcatheter injection of small doses of thrombolytic agents within the vessel, followed by deployment of a self-expandable stent. There were no complications, and the patient recovered well. Six months after stent placement, a selective renal angiogram showed excellent flow through the stented portion of the artery and normal parenchyma enhancement in the right kidney. 相似文献
97.
Ikarugi H Inoue A Yamashita T Tsuda Y Okada Y Ishii H Yamamoto J 《Thrombosis research》2005,116(5):403-408
The aim of the present study was to investigate the effect of a NO donor (GSNO) and a plasma kallikrein inhibitor (PKSI-527) alone and in combination on global haemostatic status. A new in vitro test was employed which allows the measurement of both platelet function and spontaneous thrombolysis. Sixteen healthy young and 18 elderly volunteers were enrolled in this study. When GSNO (1 mM) or PKSI-527 (20 microM) was added to native human blood, platelet reactivity was significantly inhibited in both age groups. The combination of GSNO and PKSI-527 had additive inhibitory effect on platelets. Addition of either GSNO or PKSI-527 to blood samples did not significantly affect spontaneous thrombolysis, while added together, spontaneous thrombolysis was significantly enhanced. The thrombolysis enhancing effect was more prominent in elderly subjects. Our present findings suggest that the combination of NO donor and plasma kallikrein inhibitor may have clinical antithrombotic potential. 相似文献
98.
We present a patient with rupture of a thoracic aortic aneurysm occurring after systemic infusion of tissue plasminogen activator for the treatment of acute ischemic stroke, which was successfully treated with the placement of an endovascular stent-graft. 相似文献
99.
Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study 总被引:3,自引:0,他引:3
Kollmar R Henninger N Bardutzky J Schellinger PD Schäbitz WR Schwab S 《Experimental neurology》2004,190(1):204-212
Thrombolysis (T) is limited by reperfusion-associated injury and the short therapeutic window after stroke onset. The present study investigates whether hypothermia alone or in combination with thrombolysis has beneficial effects after experimental thromboembolic stroke. Wistar rats (n = 60) were subjected to thromboembolic occlusion (TE) of the middle cerebral artery (MCA). Thrombolysis (T) was performed with intravenous recombinant tissue-plasminogen activator (rt-PA) 1 h (early T) or 3 h (late T) after TE. Hypothermia (Hy) was applied for 4 h at 33 degrees C started 1 h after TE. Experimental groups included control (C), early thrombolysis (ET), late thrombolysis (LT), hypothermia (Hy), early thrombolysis plus hypothermia (ET+Hy), and late thrombolysis plus hypothermia (LT+Hy). Animals were investigated by MRI and silver infarct staining (SIS) to assess the cerebral infarct size. All animals of group Hy survived, in contrast to 40% in group C (P < 0.05). ET+HY and LT+Hy showed a trend towards better survival as compared to ET and LT alone. PWI parameters were not significantly different between ET versus ET+HY and LT versus LT+Hy, but rt-PA administration led to improved cerebral perfusion in MRI. Significant differences in infarct volumes (T2/SIS) were found after 24 h in all treatment groups versus the control group (P < 0.05). The lesion volume calculated from T2 was significantly smaller in ET (16% +/- 5%), ET+Hy (10 +/- 4%), and LT+Hy (20% +/- 9%) after 5.5 h (10.8% +/- 4.8%) versus C (42% +/- 15%), (P < 0.05). These data indicate that hypothermia improves survival and decreases infarct volume. However, there were no significant differences between the use of rt-PA alone or in combination with hypothermia. Further studies are needed to confirm these effects, also several days after stroke onset. 相似文献
100.
Tsetis DK Katsamouris AN Androulakakis Z Chamalakis K Kostas T Chlapoutakis K Gourtsoyiannis NC 《Cardiovascular and interventional radiology》2003,26(6):572-575
The Trellis Peripheral Infusion System is an over-the-wire 0.035 guidewire compatible device, designed to isolate a region of the peripheral vasculature to allow for lytic drug infusion and dispersion. We used it successfully through a percutaneous approach in two cases of acute thrombosis of a native lower limb artery. The total amount of rt-PA used was 12 and 9 mg, respectively and was delivered through bolus injections obviating the need for a supplementary continuous infusion of the agent. The time for dissolution of thrombus was 45 and 35 minutes, respectively. No complications were observed. 相似文献